Page last updated: 2024-09-05

sorafenib and artemisinin

sorafenib has been researched along with artemisinin in 5 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(artemisinin)
Trials
(artemisinin)
Recent Studies (post-2010) (artemisinin)
6,5207305,2512,8251321,682

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Liu, Y; Xu, Z; Zhao, SJ1
Barnoin, G; Bijani, C; Cuvillier, O; Fernandez Alvarez, A; Fortin, PY; Gornitzka, H; Hemmert, C; Maddelein, ML; Qin, X; Wang, X; Zhang, C1
Cai, N; Cheng, K; Liang, H; Wen, J; Xiong, Y; Zhang, W; Zhang, Y; Zhu, J1
Bentzen, SM; Civin, CI; Emadi, A; Fox, JM; Kim, M; Kingsbury, TJ; Lapidus, RG; McCullough, S; Moses, BS; Mott, BT; Rudek, MA; Tyner, JW1
Cui, Z; Jiang, T; Li, C; Li, L; Li, S; Ma, J; Qin, T; Shi, H; Tang, T; Wang, H; Xu, W; Zhou, H1

Reviews

2 review(s) available for sorafenib and artemisinin

ArticleYear
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles

2019
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Acetaminophen; Antineoplastic Agents; Antioxidants; Apoptosis; Artemisinins; Auranofin; Cell Death; Cisplatin; Epigenesis, Genetic; Fatty Acids; Ferroptosis; Haloperidol; Humans; Indoles; Iron; Lapatinib; Mevalonic Acid; NADP; Neoplasms; Oxidation-Reduction; Oxidative Stress; Oxygen; Quinolines; Reactive Oxygen Species; Sorafenib; Spiro Compounds; Sulfasalazine; Trigonella

2020

Other Studies

3 other study(ies) available for sorafenib and artemisinin

ArticleYear
An Artemisinin-Derivative-(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity.
    Angewandte Chemie (International ed. in English), 2020, 07-13, Volume: 59, Issue:29

    Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gold; Hep G2 Cells; Humans; NF-E2-Related Factor 2; Sorafenib

2020
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.
    Blood advances, 2021, 02-09, Volume: 5, Issue:3

    Topics: Artemisinins; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Synergism; Humans; Sorafenib; Sulfonamides

2021
Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148

    Topics: Animals; Antimalarials; Artemisinins; Cell Death; Female; Ferroptosis; Humans; Malaria; Mice; Mice, Inbred C57BL; Parasites; Piperazines; Reactive Oxygen Species; Sorafenib

2022